Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Differential diagnosis of vulvar lesions

Topic Outline

GRAPHICS

INTRODUCTION

A wide spectrum of benign, premalignant, and malignant lesions may involve the vulva. The challenge to the clinician is to differentiate between normal variants, benign findings, and potentially serious disease, and this is not always easy.

The most useful means of generating a differential diagnosis of vulvar lesions is by morphologic findings (table 1) rather than by symptomatology, which is often nonspecific. Table 2 lists the most common diagnoses of vulvar lesions based on morphology (table 2A-B) [1,2], and Table 3 lists uncommon diagnoses by etiology (table 3). As with any presentation, the possibility of a multifactorial etiology should be considered.

An overview of benign vulvar lesions will be provided here. Vulvar intraepithelial neoplasia, vulvar cancer, vulvar dermatitis, and vulvodynia are discussed in detail separately (see individual topic reviews). The general approach to evaluation of vulvar lesions, including the history, physical examination, and diagnostic studies, is also reviewed separately. In all cases, one or more vulvar biopsies should be performed if the lesion is clinically suspicious for malignancy (asymmetry, border irregularity, color variation, rapid change, bleeding, non-healing). If a diagnosis cannot be made confidently by visual inspection and noninvasive methods, or if the lesion does not resolve after standard therapy, then a biopsy should also be strongly considered. (See "Vulvar lesions: Diagnostic evaluation".)

NEOPLASIA

Vulvar intraepithelial neoplasia — Vulvar intraepithelial neoplasia is a precancerous skin lesion of the vulva that may eventually progress to invasive carcinoma if left untreated. Most vulvar intraepithelial neoplasia lesions are multifocal and located in the nonhair-bearing parts of the vulva. The lesions are often raised and/or verrucous and white (picture 1A-B), but the color may be red (picture 2), pink, gray, or brown (picture 3). Macular lesions mostly occur on adjacent mucosal surfaces. (See "Vulvar intraepithelial neoplasia".)

Cancer — Most patients with vulvar cancer present with a unifocal vulvar plaque, ulcer, or mass (fleshy, nodular, or warty) on the labia. Lichen sclerosus and erosive lichen planus may predispose to vulvar cancers (picture 4). Ulcerations that do not heal, especially in postmenopausal women and women with a history of lichen sclerosis, should be biopsied [3]. (See "Vulvar cancer: Clinical manifestations, diagnosis, and pathology".)

                                                                            

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2014. | This topic last updated: Sep 14, 2012.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol 1996; 37:12.
  2. Foster DC. Vulvar disease. Obstet Gynecol 2002; 100:145.
  3. Spencer RJ, Young RH, Goodman A. The risk of squamous cell carcinoma in persistent vulvar ulcers. Menopause 2011; 18:1067.
  4. Al-Daraji WI, Wagner B, Ali RB, McDonagh AJ. Sebaceous hyperplasia of the vulva: a clinicopathological case report with a review of the literature. J Clin Pathol 2007; 60:835.
  5. Welch JM, Nayagam M, Parry G, et al. What is vestibular papillomatosis? A study of its prevalence, aetiology and natural history. Br J Obstet Gynaecol 1993; 100:939.
  6. Salvini C, De Magnis A. Multiple papillae on labia minora. CMAJ 2008; 179:799.
  7. Eilber KS, Raz S. Benign cystic lesions of the vagina: a literature review. J Urol 2003; 170:717.
  8. Oh JT, Choi SH, Ahn SG, et al. Vulvar lipomas in children: an analysis of 7 cases. J Pediatr Surg 2009; 44:1920.
  9. Garman M, Metry D. Vulvar syringomas in a 9-year-old child with review of the literature. Pediatr Dermatol 2006; 23:369.
  10. Huang YH, Chuang YH, Kuo TT, et al. Vulvar syringoma: a clinicopathologic and immunohistologic study of 18 patients and results of treatment. J Am Acad Dermatol 2003; 48:735.
  11. Miranda JJ, Shahabi S, Salih S, Bahtiyar OM. Vulvar syringoma, report of a case and review of the literature. Yale J Biol Med 2002; 75:207.
  12. Sánchez TS, Daudén E, Casas AP, García-Díez A. Eruptive pruritic syringomas: treatment with topical atropine. J Am Acad Dermatol 2001; 44:148.
  13. Gómez MI, Pérez B, Azaña JM, et al. Eruptive syringoma: treatment with topical tretinoin. Dermatology 1994; 189:105.
  14. McDougal WS. Lymphedema of the external genitalia. J Urol 2003; 170:711.
  15. D'Antonio A, Caleo A, Boscaino A, et al. Vulvar lymphoedematous pseudotumours mistaken for aggressive angiomyxoma: report of two cases. Gynecol Obstet Invest 2010; 69:212.
  16. Talwar A, Puri N, Sandhu HP. Vulval lymphoedema following pulmonary tuberculosis. Int J STD AIDS 2009; 20:437.
  17. Okur MI, Köse R, Yildirim AM, Cobanoğlu B. Lymphangiectasia of the vulva accompanying congenital lymphedema. Dermatol Online J 2009; 15:13.
  18. Adesiyun AG, Samaila MO. Huge filarial elephantiasis vulvae in a Nigerian woman with subfertility. Arch Gynecol Obstet 2008; 278:597.
  19. Lockwood-Rayermann S. Lymphedema in gynecologic cancer survivors: an area for exploration? Cancer Nurs 2007; 30:E11.
  20. Mu XC, Tran TA, Dupree M, Carlson JA. Acquired vulvar lymphangioma mimicking genital warts. A case report and review of the literature. J Cutan Pathol 1999; 26:150.
  21. Gupta SC, Misra V, Gupta AK. Cavernous lymphangioma in the vulva. Trop Doct 1998; 28:52.
  22. McCluggage WG, Smith JH. Reactive fibroblastic and myofibroblastic proliferation of the vulva (Cyclist's Nodule): A hitherto poorly described vulval lesion occurring in cyclists. Am J Surg Pathol 2011; 35:110.
  23. Cohen PR, Young AW Jr, Tovell HM. Angiokeratoma of the vulva: diagnosis and review of the literature. Obstet Gynecol Surv 1989; 44:339.
  24. Bell D, Kane PB, Liang S, et al. Vulvar varices: an uncommon entity in surgical pathology. Int J Gynecol Pathol 2007; 26:99.
  25. Gearhart PA, Levin PJ, Schimpf MO. Expanding on earlier findings A vulvar varicosity grew larger with each pregnancy. Am J Obstet Gynecol 2011; 204:89.e1.
  26. Sehgal VH, Gangwani OP. Genital fixed drug eruptions. Genitourin Med 1986; 62:56.
  27. Fischer G. Vulvar fixed drug eruption. A report of 13 cases. J Reprod Med 2007; 52:81.
  28. Malik M, Ahmed AR. Involvement of the female genital tract in pemphigus vulgaris. Obstet Gynecol 2005; 106:1005.
  29. Okoduwa C, Heller DS. Vulvar diseases of the tropics: a review. J Reprod Med 2009; 54:61.
  30. Richens J. Genital manifestations of tropical diseases. Sex Transm Infect 2004; 80:12.
  31. Edwards, L. Genital dermatology atlas. Lippincott, Williams and Wilkins 2004.
  32. Alés-Fernández M, Rodríguez-Pichardo A, García-Bravo B, et al. Three cases of Lipschutz vulval ulceration. Int J STD AIDS 2010; 21:375.
  33. Hernández-Núñez A, Córdoba S, Romero-Maté A, et al. Lipschütz [corrected] ulcers--four cases. Pediatr Dermatol 2008; 25:364.
  34. Barnes CJ, Alió AB, Cunningham BB, Friedlander SF. Epstein-Barr virus-associated genital ulcers: an under-recognized disorder. Pediatr Dermatol 2007; 24:130.
  35. Hudson LB, Perlman SE. Necrotizing genital ulcerations in a premenarcheal female with mononucleosis. Obstet Gynecol 1998; 92:642.
  36. Ishigaki H, Hatta N, Yamada M, et al. Localised vulva Langerhans cell histiocytosis. Eur J Dermatol 2004; 14:412.
  37. Triantafyllidou O, Giannakopoulos K, Pergialiotis V, et al. Pure vulvar Langerhans cell histiocytosis: a case report and literature review. Eur J Gynaecol Oncol 2009; 30:691.
  38. Fraser SJ, Pinion SB, Adamson B, Allan SJ. Vulval ulceration induced by the potassium-channel activator Nicorandil: a case series of five patients. BJOG 2009; 116:1400.
  39. Chan SK, Harris MD, Baldwin PJ, Sterling JC. Vulvovaginal ulceration during prolonged treatment with nicorandil. BJOG 2009; 116:1403.
  40. Caumes E, Gatineau M, Bricaire F, et al. Foscarnet-induced vulvar erosion. J Am Acad Dermatol 1993; 28:799.
  41. Aguirrebengoa K, González R, Oñate J, et al. [Foscarnet related vulvar ulcers. Description of 2 AIDS patients]. Enferm Infecc Microbiol Clin 1995; 13:315.
  42. Kaya TI, Tursen U, Ikizoglu G. Large genital ulcers in a patient with Behçet's disease associated with imiquimod cream treatment for external genital warts. Clin Exp Dermatol 2008; 33:783.
  43. Lynch, P, Edwards, L. Genital dermatology. Churchill Livingstone, New York 1994.
  44. Turner ML, Marinoff SC. General principles in the diagnosis and treatment of vulvar diseases. Dermatol Clin 1992; 10:275.
  45. Curtis, MG, Hopkins, MP. Glass's Office Gynecology, fifth edition. Lippincott, Williams and Wilkins 1999.